Sarcandra glabra Extract Reduces the Susceptibility and Severity of Influenza in Restraint-Stressed Mice
- PMID: 23227098
- PMCID: PMC3511833
- DOI: 10.1155/2012/236539
Sarcandra glabra Extract Reduces the Susceptibility and Severity of Influenza in Restraint-Stressed Mice
Abstract
Sarcandra glabra, as a type of "antipyretic-detoxicate drugs", has always been widely used in traditional Chinese medicine (TCM). The Sarcandra glabra extract (SGE) is applied frequently as anti-inflammatory and anti-infectious drug in folk medicine. However, relative experiment data supporting this effective clinical consequence was limited. In order to mimic the physiological conditions of the susceptible population, we employed restraint stress mouse model to investigate the effect of SGE against influenza. Mice were infected with influenza virus three days after restraint, while SGE was orally administrated for 10 consecutive days. Body weight, morbidity, and mortality were recorded daily. Histopathologic changes, susceptibility genes expressions and inflammatory markers in lungs were determined. Our results showed that restraint stress significantly increased susceptibility and severity of influenza virus. However, oral administration of SGE could reduce morbidity, mortality and significantly prolonged survival time. The results further showed that SGE had a crucial effect on improving susceptibility markers levels to recover the balance of host defense system and inhibiting inflammatory cytokines levels through down-regulation of NF-κB protein expression to ameliorate the lung injury. These data showed that SGE reduced the susceptibility and severity of influenza.
Figures
References
-
- World Health Organization. Clinical Management of Human Infection with New Influenza A (H1N1) Virus: Initial Guidance. Geneva, Switzerland: WHO; 2009. http://www.who.int/
-
- Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Critical Care Medicine. 2010;38(4):e91–e97. - PubMed
-
- Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold? Clinical Infectious Diseases. 2009;48(1, supplement):S3–S13. - PubMed
-
- Paul Glezen W. Prevention and treatment of seasonal influenza. The New England Journal of Medicine. 2008;359(24):2579–2585. - PubMed
-
- The State of Pharmacopoeia Commission of People's Republic of China. Pharmacopoeia of People's Republic of China. Beijing, China: Chemical Industry Press; 2005.
LinkOut - more resources
Full Text Sources
